Testing insulin/GLP-1 combo with CGM for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests a combination insulin/GLP-1 medicine (iGlarLixi) with continuous glucose monitoring to see how well it controls blood sugar in Chinese adults with type 2 diabetes. It may help those whose current pills are not working enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes for at least 1 year.
- You are currently taking metformin, either alone or with one other diabetes pill.
- Your blood sugar is not well controlled on your current medications.
- Your body mass index (BMI) is between 20 and 40.
- You are willing to wear a continuous glucose monitor (CGM) and check your blood sugar at home.
- You are willing to stop taking certain diabetes pills (like sulfonylureas, glinides, alpha-GI, or DPP-4 inhibitors) for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new injection that combines insulin with liraglutide works better than standard premixed insulin for people with type 2 diabetes. It aims to improve blood sugar control and simplify treatment.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
This trial tests if a once-daily injectable combination (iGlarLixi) helps control blood sugar better than usual care for people with type 2 diabetes who are already taking diabetes pills. It aims to find a more effective treatment option.
This trial tests a new combination pen (insulin degludec with liraglutide) for people with type 2 diabetes whose blood sugar is not well controlled on metformin alone or with one other pill. The goal is to see if the combination improves blood sugar control safely.
This trial tests a new GLP-1 receptor agonist to improve blood sugar control in people with type 2 diabetes. It may be an option if you haven't used a similar drug in the last three months and your medical records are complete.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
Hear when a new Type 2 Diabetes (T2D) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.